Navigation Links


PIP in Medical News

Ascension Orthopedics Introduces the Silicone PIP Implant System

AUSTIN, Texas, Feb. 13 /PRNewswire/ -- Ascension Orthopedics, Inc., a leader in orthopedic extremity implants, announces the release of the Ascension(R) Silicone PIP System at the American Academy of Orthopaedic Surgeons. This system features the smallest pre-flexed silicone proximal interphalange...

Coalition to Protect Florida's Drivers Applauds Governor Crist for Adding PIP to Special Session

TALLAHASSEE, Fla., Oct. 1 /PRNewswire-USNewswire/ -- The Coalition to Protect Florida's Drivers praised Governor Charlie Crist today for his leadership and thanked him for expanding the call of this week's special session to include no-fault auto insurance. No-fault expired at midnight today. ...

PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

... ANNAPOLIS, Md., July 27 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that it has signed definitive agre...

Partners in Policymaking Graduates New Generation of Disability Leaders

...te a new class of Partners in Policymaking (PIP) on Saturday, May 16, 2009. pip class participants, Partners, are a diverse group of highly motivated adult...wide range of backgrounds and abilities from all across Virginia. The pip Class of 2009 joins the ranks of over 325 Partners statewide with demonstra...

PharmAthene Reports Year End 2008 Financial Results

... ANNAPOLIS, Md., March 30, /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today reported operational and financial results f...

New IRC Study Documents Role of Chiropractors in Minnesota's No-Fault Auto Insurance System

...sed 30 percent, from $122 to $158 per visit. In addition, the percentage of pip claimants receiving chiropractor treatment increased approximately 5 percen...e of attorneys in the no-fault system and found that 24 percent of all 2007 pip claimants in Minnesota were represented by attorneys. Average claimed losse...

PharmAthene and Medarex Announce Additional $0.8 Million U.S. Government Appropriation for Continued Development of Anthrax Therapeutic Valortim(TM)

...PRINCETON, N.J., Nov. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biologic...ngineered strains of anthrax. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

PharmAthene to Present at the Rodman and Renshaw/Acumen BioFin 9th Annual Healthcare Conference

...pharmathene.com under the Investor Relations section, or at http://www.wsw.com/webcast/rrshq12/pip . About PharmAthene, Inc. PharmAthene (AMEX: pip ) was formed to meet the critical needs of the United States and its Allies by developing and commercializing medical countermeasures against biologic...

Hospital Coalition Says Governor's No-Fault Bill Signing Provides a 'Great Protection' for Florida Consumers

...treated at hospital emergency rooms have no health insurance and, for many, pip is their only coverage. By extending no-fault and mandatory PIP, Governor C...pital Association and a Coalition leader. Additionally, the restoration of pip means that Florida's fragile trauma care network and emergency room physici...

Hospitals and the Coalition to Protect Florida's Drivers Applaud Lawmakers for Reviving No-Fault Insurance

...age 65 has no health insurance and that, for many, pip is their only source of medical coverage, it is clear how critical pip is for both patients and the hospitals and trauma ...h drivers involved in an accident have PIP. Though pip is not mandatory until January, drivers still can ...

More>>

PIP in Medical Technology

PharmAthene Submits Proposal to BARDA in Response to Broad Agency Announcement for Advanced Research and Development for Valortim(R)

... ANNAPOLIS, Md., June 2 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that it has submitted a proposal t...

PharmAthene Submits SparVax(TM) Regulatory Strategy to FDA

... ANNAPOLIS, Md., May 22 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the Company has submitted its...

PharmAthene to Host a Conference Call and Webcast on Wednesday, April 29th at 4:30 PM to Provide an Update on the SparVax(TM) rPA Anthrax Vaccine Program

... ANNAPOLIS, Md., April 28 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it will be hosting a conferenc...

Novel Valortim(R) Mechanism of Action Data Presented at the Keystone Symposia on Molecular and Cellular Biology

... ANNAPOLIS, Md., March 31 /PRNewswire-FirstCall/ --PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that new mechanism of action data ...

PharmAthene Presents Data for Protexia(R) and Valortim(R) at 2008 BARDA Industry Conference / PHEMCE Stakeholders Workshop

... ANNAPOLIS, Md., Sept. 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company is presenting two...

Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytren's Contracture

...ients with MP contractures and seven patients with pip contractures were enrolled in the study. No measur...nd and the Proximal Intra-Phalangeal Joint, or the pip joint, which is the middle joint in the finger. Th...ts to < / = 5 degrees of normal. In CORD I, MP and pip patients were stratified in a 2:1 ratio. All pat...

PharmAthene's Recombinant Butyrylcholinesterase (rBChE) May Play A Neuroprotective Role in Alzheimer's Disease

...LIS, Md., April 9, 2008 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company specializing in the development and commercializatio...hich are exceedingly toxic. About PharmAthene, Inc. PharmAthene (Amex: pip ) was formed to meet the critical needs of the United States and its allies...

Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)

...s called the metacarpophalangeal joint, or MP joint, which is the joint closest to the palm of the hand and the proximal interphalangeal joint, or the pip joint, which is the middle joint in the finger. The little finger and ring finger are most frequently involved. (1) Badalamente, M. A., Hurst, L. C. ...

More>>

PIP in Medical Products

Bunnell Mini-Modified Safety Finger Pin

Description:... Bunell Mini-Modified Safety Finger Pin reduces pip flexion contractures....
Company:AliMed, Inc.

Banana Split Splint

Description:... The Banana Split Splint reduces pip joint or DIP joint flexioncontractures of any degree. Hinged design is easy to put on. Soft gel-lining cushions injured fingers so treatment to straig...
Company:3-Point Products

Finger Sled

Description:...ning and non-slip fit. FingerSled splints can be worn at night to lessen stress on fingers with Osteoarthritis, for correction following injury to the pip joint or DIP joint of the fingers. Use after surgery to repair collateral ligament injuries. Each FingerSled Splint can be used to correct either medi...
Company:3-Point Products

FoamWrap™ Final Flexion Wrap

Description:... FoamWrap Final Flexion Wraps restore full pip joint or DIP joint flexion following injury or when lost due to arthritic changes. Unparalleled in comfort and softness, the breathable, foam-lined ma...
Company:3-Point Products

HARMONY® Orthopedics

Description:...al records, demographic information, insurance reporting, medication monitoring, admission scheduling, radiology orders & reports, laboratory results, pip and Comp. Patient Management....
Company:Medical Technology International

NeuFlex™ MCP/PIP Finger Joint Implant Systems

Description:... The design of the NeuFlex™ MCP and/or pip Finger Joint Implant is based on numerous research studies of the structure and mechanics of the MCP/PIP joint. This prosthesis is inserted into metac...
Company:DePuy Orthopaedics, Inc.

The Avanta Soft Skeletal Hand Implant System

Features:... The Avanta MCP and pip Soft Skeletal Implants constructed of Silflex II advanced elastomer, offer ...h accommodates the specific, unique biomechanics and anatomy of the MCP and pip joints. Each product has supporting instruments consisting of color cod...
Company:Small Bone Innovations, Inc.

EU-M60 Endoscopic Ultrasound Center

Features:...ear images at the same time A sub-screen is available so you can view ultrasound images on the main screen and endoscopic images on the 2-position pip format Expanded imaging functionality allows greater and easier control over CONTRAST, GAIN STC, FREQUENCY, Gamma Curve, and post-processing opera...
Company:Olympus America Medical

More>>

PIP in Biological Technology

PharmAthene to Host Second Quarter 2009 Conference Call and Webcast on Thursday, August 13, 2009

... ANNAPOLIS, Md., Aug. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

... ANNAPOLIS, Md., July 31 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that, effective July 28, 2009, it ...

PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review

... ANNAPOLIS, Md., July 9 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today announced that the U.S. Food and Drug Admini...

PharmAthene Reports First Quarter 2009 Financial and Operational Results

... ANNAPOLIS, Md., May 15 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, today reported financial and operational results f...

PharmAthene Announces New Date for First Quarter 2009 Conference Call and Webcast

... ANNAPOLIS, Md., May 8 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced a date change for its first quarter 2009 ...

PharmAthene to Host First Quarter 2009 Conference Call and Webcast on Thursday, May 14, 2009

... ANNAPOLIS, Md., May 7 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

PharmAthene Presents Data for SparVax(TM), a Novel Vaccine for the Prevention and Treatment of Anthrax Infection, at the 12th Annual Conference on Vaccine Research

... ANNAPOLIS, Md., April 28 /PRNewswire/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that results from a second Phase I...

PharmAthene Announces $5.5 Million Public Equity Offering

... ANNAPOLIS, Md., March 24 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: pip ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that certain institutional investo...

PharmAthene To Host Year-End 2008 Earnings Conference Call and Webcast on Monday, March 30, 2009

... ANNAPOLIS, Md., March 19 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: pip ) a biodefense company developing medical countermeasures against biological and chemical threats, announced today that its financial results for the ...

PAREXEL Experts to Present Leading Insights at Drug Information Association 21st Annual Euromeeting

...atric Investigation Plan (PIP) Advisory from PAREXEL Consulting, with an update and guidance on how biopharmaceutical companies should address the new pip requirements, will be provided at PAREXEL's Booth #1522 . PAREXEL experts will also be available at the booth to hold exclusive executive briefings w...

More>>

Other TagsinstrumentationMetabolitesMetabolitesHTSHTSHTSHTSHTSReadReadReadReadReadRead
(Date:11/27/2009)... Biotech firm Replikins Ltd. tod...1N1 virus genomic data. It shows that the lethali...s.d. 4.5) during the virus,s current outbreak in t...his week of 2.0 (s.d. 0.1). The H1N1 infectivity c... Boston (PRWEB) November 27, 2009 -- Bio...
(Date:11/27/2009)... , NEUILLY-SUR-SEINE, France, Nov. 27 /PRNewsw... professional cycling team dedicated to ethical sp...ng champions, announced today that it will become ...itions Optical as a new sponsor of the team. Trans... of adaptive eyewear, offering the most advanced p...
(Date:11/27/2009)... rates to bring unprecedented medical, economic bu...7 (HealthDay News) -- The number of people with di...over the next 25 years, a new study predicts. ,...million people with the disease, up from 23.7 mill...ating people with diabetes will triple, the study ...
(Date:11/27/2009)... Specialist manufacturers who us...s are saving millions of dollars by bringing in te...ss. Increasing numbers of pro-active medical manuf...at the concept stage of their projects, ensuring t...esign processes or potentially outdated technology...
(Date:11/26/2009)...e next 25 years, the number of Americans living wi....7 million in 2009 to 44.1 million in 2034. Over t...riple, rising from $113 billion to $336 billion, e... researchers based at the University of Chicago re... The number of those with diabetes covered by Medi...
Breaking Medicine News(10 mins):Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3
(Date:11/24/2009)...t keep weakened and flabby arteries from collapsin..., those stents are no longer needed -- once the ar...Previously, doctors had no choice but to leave the... University,s Department of Biomedical Engineering... that carries drugs where they,re needed, then dis...
(Date:11/24/2009)...UGE Antarctica has long held secrets of the earth...ently, there has been very little information on t...s of ice for millions of years. Now, a team of res...ve been funded to the tune of $10 million dollars ... to the bottom of things literally. These scienti...
(Date:11/23/2009)...New research presents strong evidence that the "sy...utdoor traffic-related pollution and indoor endoto...or the other exposure alone. , Environmental h...UC) College of Medicine have shown that children e...icles and indoor endotoxin during early life are s...
Breaking Biology News(10 mins):A coating for life 2LSU gets to the bottom of things -- in Antarctica 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2ICL Reports Continued Sequential Improvement for Third Quarter of 2009 62011 1ICL Reports Continued Sequential Improvement for Third Quarter of 2009 62011 2ICL Reports Continued Sequential Improvement for Third Quarter of 2009 62011 3ICL Reports Continued Sequential Improvement for Third Quarter of 2009 62011 4ICL Reports Continued Sequential Improvement for Third Quarter of 2009 62011 5ICL Reports Continued Sequential Improvement for Third Quarter of 2009 62011 6ICL Reports Continued Sequential Improvement for Third Quarter of 2009 62011 7Jackson 26amp 3B Coker Industry Report Addresses Health Care Reform 62010 1Jackson 26amp 3B Coker Industry Report Addresses Health Care Reform 62010 2Jackson 26amp 3B Coker Industry Report Addresses Health Care Reform 62010 3Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 62008 1Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 62008 2Slate Capital Group and New Markets Venture Partners Acquire eCoast Sales Solutions 62008 3
Other Contentsphagocytosisphagocytosisphagocytosispharynxpharynxpharynxvariancevariancevariancephenotypicphenotypicphenotypicphenotypicphosphatasephosphatasephosphatasephosphatasephosphatasephosphatasephosphatasegroupgroupgroupgroupgroupgroupgroupgroupgroupgroupphosphodiesterphosphodiester